23 Jun 2025 – Buckinghamshire, UK

Radcliffe Group is delighted to report strong Impact Factor growth across its journals in the latest Journal Citation Reports^™ (2024) from Clarivate^™. This progress highlights the strength and influence of Radcliffe’s cardiovascular portfolio, made possible by the dedicated efforts of its editorial teams, authors, and reviewers.

Cardiac Failure Review (CFR), under the leadership of Prof Andrew Coats, has achieved a remarkable rise in its Impact Factor, increasing from 4.2 to 5.7. This achievement places CFR in the prestigious first quartile (Q1), solidifying its position among the top open access journals in the cardiovascular field.

European Cardiology Review (ECR), led by Prof Juan-Carlos Kaski, Associate Editor Prof Bianca Rocca, and Deputy Editor Prof Pablo Avanzas, also showed significant growth, increasing from 3.2 to 3.6, placing it firmly at the top of the Q2 category.

Arrhythmia & Electrophysiology Review (AER), under the direction of Dr Demos Katritsis, rose from 2.6 to 3.3, marking another significant milestone.

Interventional Cardiology: Reviews, Research, Resources (ICR³), overseen by Dr Peter O’Kane, Deputy Editors Dr Giuseppe Ando and Dr John Rawlins, grew from 2.5 to 2.8, solidifying its place in Q2.

Radcliffe Group extends its sincere thanks to all contributors whose commitment and expertise have helped elevate the quality and visibility of its journals. These achievements reinforce the company’s mission to support the advancement of cardiovascular science and education through high-quality, accessible research.